| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9380466 | Journal of Affective Disorders | 2005 | 6 Pages |
Abstract
These findings support the implication of beta-arrestin1 in the pathophysiology of major depression and in the mechanism underlying antidepressant-induced receptor down-regulation and therapeutic effects. Beta-arrestin1 measurements in patients with depression may potentially serve for biochemical diagnostic purposes and for monitoring and predicting response to antidepressants.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
A. Matuzany-Ruban, S. Avissar, G. Schreiber,